These findings demonstrate that TWEAK/Fn14 axis-triggered non-canonical NF-κB signaling pathway activation in cancer cells can positively or negatively regulate cellular invasive activity, depending on the particular cancer cell line under investigation. The gene discussed is TNFRSF12A; the disease is cancer.